به جمع مشترکان مگیران بپیوندید!

تنها با پرداخت 70 هزارتومان حق اشتراک سالانه به متن مقالات دسترسی داشته باشید و 100 مقاله را بدون هزینه دیگری دریافت کنید.

برای پرداخت حق اشتراک اگر عضو هستید وارد شوید در غیر این صورت حساب کاربری جدید ایجاد کنید

عضویت

جستجوی مقالات مرتبط با کلیدواژه "pulmonary infection" در نشریات گروه "پزشکی"

  • Oğuz Karcıoğlu, Ayşen Kara, Olcay Kurtulan, Serknan Uysal, Ziya Selçuk

    Echinococcus granulosus remains a global public health issue. Although predominantly affecting the liver, the lungs are the second most affected organ and often undergo surgical intervention. Here, a case managed by bronchoscopy and medical therapy is presented. A 26-year-old woman was presented with a cough, hemoptysis, and a 5 kg weight loss in the last two months. Chest imaging identified a 4 cm centrally cystic mass lesion in the middle lobe of the right lung, which was suspicious of lung cancer. Bronchoscopy revealed a whitish, plastic-like object that was difficult to extricate and obstructed the middle lobe bronchus. We removed the material and purulent secretions covering it and opened the middle lobe bronchus totally. The histopathological study verified its consistency with hydatid cyst. There was no evidence of a hydatid cyst on computerized thomography after bronchoscopy. The lesion in the left lobe of the liver, confirmed to be suggestive of a hydatid cyst via ultrasonography, was treated using the PAIR technique. We administered oral albendazole to continue the treatment. It may be a reasonable approach to postpone surgery in order to preserve lung tissue in patients who have undergone complete removal of hydatid cyst material via bronchoscope.

    Keywords: Parasites, Echinococcus Granulosus, Pulmonary Infection, Hemoptysis, Hydatid Cyst
  • Ruiping Li, Wei Song *, Donglan Mei
    Background
    Severe chronic obstructive pulmonary disease (COPD) patients with pulmonary infections face higher morbidity and mortality.
    Objective
    To investigate mononuclear cell membrane CD14 as a prognostic marker for their outcome.
    Methods
    A total of 311 participants were included: 122 in the coinfection group, 127 in the severe COPD group, and 62 in the control group. The patients in the coinfection group were categorized into survival (n=106) and death (n=16) groups based on hospitalization prognosis. The CD14%, CD14MFI, and CD14IND values were compared between the groups. Death risk factors were assessed by COPD grading, FEV1% pred, FEV1/FVC, CD14%, CD14MFI, and CD14IND. Correlations between CD14 parameters and mortality, COPD grade, FEV1%pred, and FEV1/FVC were analyzed. The critical value for CD14IND to predict patient death was determined and survival rates were compared between the high and the low-risk groups.
    Results
    CD14% values were significantly lower in the COPD and co-infection groups than in the control groups (p<0.05). The survival group showed a steady increase in mCD14 expression, while the death group showed fluctuating low levels. Low value of CD14% was identified as a risk factor for death and correlated with mortality and COPD severity (p<0.001). CD14IND≤74.36 predicted death with 91.22% sensitivity and 95.51% specificity. The high-risk group had a significantly lower 30-day survival rate (68.42%) compared with the low-risk group (95.24%) (log-rank χ2=10.067, p=0.002).
    Conclusion
    The CD14 parameters of mononuclear cell membranes prove to be promising markers for predicting prognosis and death in severe COPD patients with lung infection.
    Keywords: Mononuclear Cell Membrane CD14, Predicted Value, Prognosis, Pulmonary Infection, Severe COPD
  • Azam Heidari, Samad Ghodrati, Ahmadreza Mobaien, Asghar Fazaeli*
    Background

    Lophomonas blattarum is a newly reported opportunistic protozoan parasite that may cause pulmonary infections. Co-morbidity of this parasite and pulmonary viral infections, such as COVID-19 may exacerbate their pathological effects. This study aimed to evaluate the prevalence of L. blattarum infection in patients with COVID-19 infection.

    Methods

    In this study, mini bronchoalveolar lavage (mini-BAL) samples were taken from 93 patients with acute pneumonia due to COVID-19 infection in 2021. The samples were subjected to microscopic examination for the presence of L. blattarum, following smear preparation and staining with two specific methods of Giemsa and Papanicolao.

    Results

    The patients included 49 males and 44 females with a mean age of 68.8 ± 14.8 years. Of the specimens studied after staining, only one specimen (1.08%) was positive for L. blattarum. It was found in a patient with diabetic underlying disease.

    Conclusion

    It was concluded that the infection of L. blattarum in patients with severe COVID-19 pneumonia was low. However, the presence of this parasite in this group of patients should not be neglected. This is the first report of pulmonary infection with this protozoan parasite in Zanjan Province.

    Keywords: Lophomonas blattarum, COVID-19, Pulmonary Infection, Co-infection, Severe pneumonia
  • Theodore Dharma Tedjamartono *, Gembong Satria Mahardhika, Haidar Zain

    COVID-19 is a major emerging disease that will affect any specific disease. However, a recent report suggests the occurrence of hyperglycemia without any present diabetes in COVID-19 patients. This study aimed to systematically review recent evidence on hyperglycemia in COVID-19 patients. Literature research was done using four search engines, consist of Google Scholar, PubMed, ScienceDirect, and ProQuest, and limited to English manuscripts only and published in the last 1 year. SARS-CoV-2 could damage the pancreas by causing the destruction of the β-cell structure that leads to impairment of glucose metabolism and worsen pre-existing diabetes or determine the appearance of hyperglycemia in non-diabetes. Inflammation also plays a major important role in hyperglycemia related to COVID-19. Hyperglycemia increased the vulnerability of the lung, by promoting and facilitating the entry of the SARS-CoV-2 into the host cells, and decreasing lung function. Moreover, the mortality and morbidity rate conceivable increased due to hyperglycemia. The presence of high glucose levels is linked with the progression of COVID-19 severity. Thus, the glucose level should be concerned, either in a patient with present diabetes or without any presence of diabetes. Examination and monitoring of glucose levels might be a useful tool to prevent the seriousness of COVID-19.

    Keywords: Diabetes Mellitus, SARS-CoV-2, High Glucose Level, Pulmonary Infection
  • Omid Moradi Moghaddam, Mohammad Niakan Lahiji, Mahshid Talebi, Taher, Behnam Mahmoodiyeh *
    Background
    Ventilator-Associated Pneumonia (VAP) is a hospital pneumonia that is considered in patients on mechanical ventilation for at least 48 hours with symptoms of new lower respiratory tract infections being reported in them. The present study reviews the effect of adding inhaled colistin in the treatment of ventilator-induced pulmonary infections in Intensive Care Unit (ICU) patients.
    Materials and Methods
    In this single blind clinical trial, patients admitted to the ICU with diagnosis of pulmonary infections caused by ventilator were investigated. In the treatment group, patients received 150 mg of colistin plus 1,000,000 units inhaled colistin every eight hours and in the control group only 300 mg of colistin every eight hours intravenously was given. Patients were followed up in terms of clinical findings for seven days after the initial diagnosis of infection.
    Results
    The results of this study showed that administration of inhaled colistin in patients admitted in ICU significantly improved culture indices, leukocyte, white blood cell count, chest X-ray, chest secretion, CPIS score and saccharification (SpO2) on the third and seventh days after treatment compared to the first day.
    Conclusion
    Considering the positive effect of adding inhaled colistin to the treatment of patients admitted to ICU with pulmonary infections caused by ventilator with multi-drug resistant Acinetobacter, the use of combination drug therapy is recommended.
    Keywords: Pulmonary infection, ICU, Inhaled colistin
  • مسعود فلاحی، حسنعلی کریم پور، جواد امینی سامان، سعید محمدی، اعظم شریفی، علیرضا جهانبخش، مسعود مدرسی، مریم میرزایی، رسول کاویان نژاد *
    سابقه و هدف
    پنومونی وابسته به ونتیلاتور یک عارضه شایع، جدی و پرهزینه در بخش مراقبت های ویژه است که رتبه اول عفونت های بیمارستانی را به خود اختصاص می دهد. از این رو، انجام مداخلات لازم جهت پیشگیری از آن لازم و ضروری به نظر می رسد. گیاه اکالیپتوس دارای خواص آنتی بیوتیکی می باشد، لذا هدف از این پژوهش بررسی اثرات بخور اکالیپتوس در پیشگیری از پنومونی در بیماران دارای لوله تراشه و تحت ونتیلاتور در بخش مراقبت های ویژه است.
    مواد و روش ها
    این مطالعه کار آزمایی بالینی دو سو کور بر روی 100 بیمار دارای لوله تراشه و تحت ونتیلاتور در دو گروه و در بخش مراقبت های ویژه بیمارستان امام رضا شهر کرمانشاه انجام شد. در گروه مداخله (50n=) مقدار 4 سی سی از محلول اکالیپتوس 2 درصد با 6 سی سی آب مقطر و در گروه کنترل (50n=) 10 سی سی آب مقطر روزی سه بار از طریق کیت نبولایزر متصل به دستگاه های تهویه مکانیکی داده شد. نتایج دو گروه در مورد میزان عفونت ریوی زودرس و دیررس بر اساس معیار CPIS با استفاده از آزمون های کای دو و تی تست مقایسه شدند.
    یافته ها
    میزان بروز پنومونی زودرس و دیررس در گروه مداخله کم تر از کنترل بود، این کاهش به صورت معنی دار در پنومونی دیررس مشاهده شد (01/0=p). شروع زمان پنومونی ناشی از تهویه مکانیکی به صورت معنی داری در گروه مداخله دیرتر از گروه کنترل بود (01/0=p).
    استنتاج
    با توجه به نتایج پژوهش، اکالیپتوس به عنوان یک درمان پروفیلاکسی یا تاخیر در بروز عفونت ریوی در بیماران تحت ونتیلاتور موثر است. استفاده از این گیاه به شکل بخور در بیماران دارای لوله تراشه پیشنهاد می شود.
    کلید واژگان: عفونت ریوی, تهویه مکانیکی, اکالیپتوس, بخش مراقبت های ویژه
    Masoud Fallahi, HasanAli Karimpour, Javad AminiSaman, Saeed Mohammadi, Azam Sharifi, Alireza Jahanbakhsh, Masoud Modarresi, Maryam Mirzaei, Rasol Kawyannejad *
    Background and purpose
    Ventilator-associated pneumonia is a common, serious and costly disorder in intensive care units (ICUs) that rank first in hospital infections. So, appropriate interventions are needed to prevent this condition. Eucalyptus is a plant with antibiotic properties, therefore, current study aimed at investigating its effects on prevention of endotracheal tube-associated pneumonia in ICU.
    Materials and methods
    A double-blind clinical trial was performed in 100 patients with endotracheal tube and on ventilator in ICU in Kermanshah Imam Reza Hospital, Iran. The patients were divided into two groups. In intervention group (n=50) 4 cc of 2% eucalyptus solution was mixed with 6 cc distilled water and in control group (n=50) 10 cc distilled water was given three times daily through a nebulizer kit connected to mechanical ventilation devices. Data on the rate of early and late pneumonia were compared based on CPIS criteria applying t-test and Chi-square.
    Results
    The incidence of early and late pneumonia was lower in intervention group compared to that of the controls. The decrease was significantly more in onset of late pneumonia (P=0.01). The onset of pneumonia due to mechanical ventilation was significantly higher in intervention group than that of the control group (P=0.01).
    Conclusion
    Eucalyptus was found to be an effective prophylaxis that could delay the development of pulmonary infection in patients on ventilation. Therefore, it is suggested in ICUs in patients with tracheal tubes.
    Keywords: pulmonary infection, mechanical ventilation, eucalyptus, Intensive Care Unit
  • Masoud Ataiekhorasgani, Nasim Jafaripozve, Omid Zaerin

    Streptomyces are saprophytic soil organisms rarely known to cause invasive infections. Streptomyces is the largest genus, producing antibacterial, antifungal and antiparasitic drugs. The case was a 24-year-old man, admitted for sudden dyspnea, fever and sputum and decreased sound in the left lung. The chest X-ray showed hydropneumothorax. After chest tube insertion, lung expansion did not happen. Pleural effusion was exudative with gram-positive bacillus and Streptomyces in culture. Owing to symptoms of Cushing in history, examination and laboratory work-up for Cushing was done and finally he underwent bilateral adrenalectomy. The patient was on antibiotic broad spectrum antibiotic and then was changed to antibiotic as organism was sensitive to and discharged with clarithromycin for 6 months. Streptomyces happens in immunodeficient patient. Diagnosis is based on culture and contamination was ruled out. Treatment period is longer for patients owing to slow growing nature.

    Keywords: Cushing syndrome, pulmonary infection, Streptomyces
  • Soheila Khalilzadeh, Mohammad Reza Boloorsaz, Nooshin Baghaie, Shahin Hakimi, Ali Akbar Velayati
    Background
    Bronchiectasis in childhood is still one of the most common causes of childhood morbidity in developing countries. The management of these patients remains problematic, and there are few studies of long-term outcome. The aim of this retrospective study was to define the general characteristics, underlying causative factors, radiologic and laboratory findings of bronchiectatic patients.
    Materials And Methods
    Forty-six patients with bronchiectasis, who had referred to National Research Institute of Tuberculosis and Lung Disease (NRITLD) in Iran, were reviewed during a 6-year period (1999-2005). General characteristics and underlying causes were recorded from the medical reports.
    Results
    Mean age of patients was 12.39 ± 4.1 years at presentation. Forty-six percent were females and 54% were males. The most common clinical symptom was chronic productive cough. According to HRCT-Scan results, RML and lingula were the main affected regions. The most common etiology of bronchiectasis was idiopathic followed by cystic-fibrosis and mucociliary dyskinesia. Four patients with CF expired due to pulmonary insufficiency.
    Conclusion
    In conclusion, bronchiectasis remains a disease of concern to pediatricians, particularly in developing countries. Infections are still important causes of bronchiectasis, and clinical improvement can be achieved by appropriate medical and supportive treatment. Although medical treatment is the mainstay of management, surgery should be considered in selected patients.
    Keywords: Bronchiectasis, Children, Pulmonary infection
  • مهرناز رسولی نژاد، حدیثه هوسمی رودسری، میترا مهدوی مزده، محبوبه حاجی عبدالباقی، فرخ لقا احمدی
    مقدمه
    پیوند کلیه درمان ایده آل نارسایی مزمن کلیوی می باشد و عفونت ریوی یکی از شایعترین و جدی ترین عفونت های پس از پیوند بوده که احتیاج به بستری پیدا کرده و با مورتالیتی بالایی همراه است. بدلیل استفاده از رژیم سرکوبگر ایمنی، شانس عفونت افزایش یافته، درحالیکه واکنش های التهابی کاهش می یابد، علایم و نشانه های بالینی و حتی رادیولوژیک در این بیماران غیر واضح بوده و گاه ارگانیسم های غیر معمول در بروز آن نقش دارند.
    مواد و روش ها
    بین تیرماه 1380 تا تیرماه 1381، 164 بیمار پیوند کلیوی در یک مطالعه Case series بصورت آینده نگر مورد بررسی قرار گرفتند.
    یافته ها
    از این میان، 14 مورد (8.5%) عفونت ریوی داشتند. 11 بیمار (78.6%) مونث و 3 بیمار (21.4%) مذکر بودند. میانگین سنی بیماران پیوند کلیوی با عفونت ریه 42.6 سال بوده تا حداقل آن 21 و حداکثر آن 68 سال بود. تمامی بیماران تحت درمان با سه دارو سرکوب کننده ایمنی بودند. پیگیری نتایج درمان 9 تا 12 ماه انجام شد. زمان شروع عفونت ریوی بین 2 ماه تا 10 سال پس از پیوند بود. شروع عفونت در 3 مورد (21.4%) در پریود یک تا شش ماه پس از پیوند، 11 مورد (78.6%) پس از شش ماه و کلا 7 مورد (50%) کمتر از یکسال پس از پیوند بوده است. هیچ موردی در ماه اول بعد از پیوند مشاهده نشد. از بین 14 بیمار با پنومونی، در شش مورد (42.8%) از شستشوی برونکوآلونولار جهت رسیدن به تشخیص استفاده شد. شایعترین تظاهر بالینی بیماران تب و شایعترین جرم جدا شده مایکوباکتریم توبرکلوزیس بود. بیماری سل در 3.65% کل بیماران پیوندی دیده شد. یک مورد موکورمایکوز ریوی یافت شد. در مواردی که جرم بدست نیامد با احتمال پنومونی اکتساب جامعه درمان Emprical شروع شد. تمام بیماران توبرسلی پاسخ مناسب به درمان دادند. در کل بیماران پنومونی، یک مورد فوت بدلیل موکورمایکوز ریوی وجود داشت.
    نتیجه گیری و توصیه ها: تشخیص قطعی عامل ایجاد کننده پنومونی در پیش آگهی نقش مهمی دارد و جهت تشخیص قطعی و بموقع، استفاده از روش های تهاجمی توصیه شده که به این طریق موربیدیتی و مورتالیتی عفونت پس از پیوند کاهش می یابد.
    Rassulinejad M., Hossami Roodsari H., Mahdavi Mazdeh M., Hajiabdolbaghi M., Ahmadi F. L
    Renal transplantation is ideal treatment of chronic renal failure. Pulmonary infection is a common and serious post transplant infection requiring hospitalization and is associated with high mortality. Increased susceptibility to infection is due to a decrease in the patient's immunological response caused by immunosuppression through drug administration, and by other influences.
    Materials And Methods
    This study was case series and prospective, from July 2001 to July 2002 in Imam Khomeini hospital of Tehran.
    Results
    164 renal transplant recipients were studied, 14 patients (8.5%) had pulmonary infection, 11 of them (78.6%) were female and 3 (21.4%) were male. The mean age of them was 42.6 years. The patients were followed up for 9 to 12 months. All patients were on triple immunosuppressive regimens. The interval between transplantation and the appearance of pneumonia was 2 months to 10 years. The time of beginning infection in 3 cases (21.4%) was between 1 to 6 months post transplantation, 11 cases (78.6%) were occurred beyond 6 months after transplantation. In 7 cases (50%), pulmonary infection was occurred during first year after transplantation. None of the 14 patients developed pulmonary infection in first month after transplantation. BAL were used in 6 cases (42.8%) of pulmonary infection, and organism were detected in 5 of them (83.3%). The most common clinical feature was fever. Six cases were due to mycobacterium tuberculosis (42.9%), this organism was the most common ethiology of pneumonia. In this study tuberculosis was seen in 3.6% of renal transplant recipients. One patient had pulmonary mucormycosis. All patients with pulmonary TB were cured, and other cases with unknown case, were cured with empirical treatment.
    Conclusion
    Our finding indicate the invasive diagnostic procedures are required in order to earlier and reliable diagnosis and then better outcome of transplantation.
    Keywords: pulmonary infection
نکته
  • نتایج بر اساس تاریخ انتشار مرتب شده‌اند.
  • کلیدواژه مورد نظر شما تنها در فیلد کلیدواژگان مقالات جستجو شده‌است. به منظور حذف نتایج غیر مرتبط، جستجو تنها در مقالات مجلاتی انجام شده که با مجله ماخذ هم موضوع هستند.
  • در صورتی که می‌خواهید جستجو را در همه موضوعات و با شرایط دیگر تکرار کنید به صفحه جستجوی پیشرفته مجلات مراجعه کنید.
درخواست پشتیبانی - گزارش اشکال